Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IGA Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnrolling By InvitationNCT07135219
What this trial is testing

Cizutamig in Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Peking University First Hospital 15
Large-scale testing (Phase 3)Study completedNCT00437463
What this trial is testing

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Who this might be right for
Glomerulonephritis
Sanofi 60
Not applicableStudy completedNCT00004305
What this trial is testing

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 105
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Large-scale testing (Phase 3)Active Not RecruitingNCT06564142
What this trial is testing

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex 605
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07785128
What this trial is testing

Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Shaheed Suhrawardy Medical College and Hospital 104
Large-scale testing (Phase 3)Looking for participantsNCT07024563
What this trial is testing

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Who this might be right for
IgANIgAVNImmunoglobulin A Nephropathy+3 more
Alexion Pharmaceuticals, Inc. 36
Large-scale testing (Phase 3)UnknownNCT02187900
What this trial is testing

Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.

Who this might be right for
IgA Nephropathy
Second Xiangya Hospital of Central South University 300
Post-approval studies (Phase 4)UnknownNCT02765594
What this trial is testing

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Peking Union Medical College Hospital 98
Not applicableStudy completedNCT01237028
What this trial is testing

Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers

Who this might be right for
IgA Nephropathy
Yonsei University 168
Not applicableLooking for participantsNCT07056595
What this trial is testing

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Who this might be right for
IgA Nephropathy (IgAN)
Botkin Hospital 30
Post-approval studies (Phase 4)Looking for participantsNCT04662723
What this trial is testing

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Who this might be right for
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena 878
Early research (Phase 1)Study completedNCT05174221
What this trial is testing

Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Who this might be right for
Kidney DiseaseGlomerulonephritis
Takeda 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06830395
What this trial is testing

Study of CM313 in Subject With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Keymed Biosciences Co.Ltd 106
Post-approval studies (Phase 4)Study completedNCT00367562
What this trial is testing

Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

Who this might be right for
IGA Nephropathy
Hospital Britanico 20
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Large-scale testing (Phase 3)Enrolling By InvitationNCT05248659
What this trial is testing

Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 600
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807995
What this trial is testing

Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Vertex Pharmaceuticals Incorporated 605
Not applicableUnknownNCT05320133
What this trial is testing

Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Peking University First Hospital 80
Testing effectiveness (Phase 2)Study completedNCT05016323
What this trial is testing

Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.

Who this might be right for
IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 316
Next Page